My Bibliography

select

Dwivedi V, Davis J, Wilson E, Scott M, Zelan M, DeFeo N, Huffman V, Cooke R, O"Daniel K, Riese 2nd DJ. Stable transfection of plasmid DNA into adherent rodent cell lines using calcium phosphate. protocols.io. 2024 February. doi: dx.doi.org/10.17504/protocols.io.rm7vzxz5rgx1/v1.

select

Wilson E, Scott M, Dwivedi V, Zelan M, Riese 2nd DJ. Recombinant retroviral vectors that express EGF, TGFalpha, NRG2beta, and the NRG2beta Q43L mutant. protocols.io. 2024 February. doi: 10.17504/protocols.io.kxygx3d6og8j/v1.

select

Wilson E, Scott M, Zelan M, Dwivedi V, Riese 2nd DJ. Recombinant retroviral expression vectors that encode dominant-negative mutant alleles of EGFR and ERBB2. protocols.io. 2024 February. doi: 10.17504/protocols.io.bp2l6x5w1lqe/v1.

select

Dwivedi V, Riese 2nd DJ. Cell Culture Reagents and Sources – 2023-08-30. protocols.io. 2023 August. doi: 10.17504/protocols.io.261ged55wv47/v1.

select

Riese 2nd DJ, Dwivedi V. A recombinant retroviral expression vector (pLXSN-HygR) based on pLXSN that confers resistance to hygromycin and pLXSN-HygR derivatives that encode EGFR, ERBB2, or ERBB3. protocols.io. 2023 August. doi: 10.17504/protocols.io.j8nlkooq1v5r/v1.

select

Riese 2nd DJ. Recombinant retroviral expression vectors based on pLXSN that encode EGFR, ERBB2, ERBB3, and ERBB4. protocols.io. 2023 August. doi: 10.17504/protocols.io.261gedd97v47/v1.

select

Lucas LM, Cullum RL, Woggerman JN, Dwivedi V, Markham JA, Kelley CM, Knerr EL, Cook LJ, Lucas 2nd HC, Watts DS, Ghosh TM, Halanych KM, Gupta RB, Riese 2nd DJ. ERBB4 mutant alleles found in BRAF WT melanomas that drive the proliferation of a BRAF WT melanoma cell line. medRxiv. 2023 June. doi: 10.1101/2022.06.21.22276707.

select

Lucas LM, Cullum RL, Dwivedi V, Markham JA, Woggerman JN, Kelley CM, Knerr EL, Cook LJ, Lucas 2nd HC, Waits DS, Ghosh TM, Halanych KM, Gupta RB, Riese 2nd DJ. ERBB4 Drives the Proliferation of BRAF-WT Melanoma Cell Lines. medRxiv. 2023 June. doi: 10.1101/2022.06.20.22276663.

select

Lucas LM, Dwivedi V, Senfeld JI, Cullum RL, Mill CP, Piazza JT, Bryant IN, Cook LJ, Miller ST, Lott JH 4th, Kelley CM, Knerr EL, Markham JA, Kaufmann DP, Jacobi MA, Shen J, Riese DJ 2nd. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381. Review. PubMed PMID: 34987087.

select

Cullum RL, Riese 2nd DJ. The Simulated Random Assignment of Missense Mutations Throughout a Gene of Interest Can Determine Whether Missense Mutations Found in That Gene in a Population of Tumor Genomes Are Non-Randomly Distributed. Protocols.io. 2021 October. doi: 10.17504/protocols.io.bwtwpepe.

select

Cullum RL, Lucas LM, Senfeld JI, Piazza JT, Neel LT, Whig K, Zhai L, Harris MH, Rael CC, Taylor DC, Cook LJ, Kaufmann DP, Mill CP, Jacobi MA, Smith FT, Suto M, Bostwick R, Gupta RB, David AE, Riese Ii DJ. Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. PLoS One. 2020;15(12):e0243901. doi: 10.1371/journal.pone.0243901. eCollection 2020. PubMed PMID: 33378376; PubMed Central PMCID: PMC7773179.

select

Shi Y, Riese DJ 2nd, Shen J. The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer. Front Pharmacol. 2020;11:574667. doi: 10.3389/fphar.2020.574667. eCollection 2020. Review. PubMed PMID: 33363463; PubMed Central PMCID: PMC7753359.

select

Kabir FML, DeInnocentes P, Agarwal P, Mill CP, Riese Nd DJ, Bird RC. Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer. J Vet Sci. 2017 Jun 30;18(2):149-158. doi: 10.4142/jvs.2017.18.2.149. PubMed PMID: 27515268; PubMed Central PMCID: PMC5489461.

select

Kanthala S, Mill CP, Riese DJ 2nd, Jaiswal M, Jois S. Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells. Protein Expr Purif. 2016 Sep;125:26-33. doi: 10.1016/j.pep.2015.09.001. Epub 2015 Sep 9. PubMed PMID: 26363121; PubMed Central PMCID: PMC4785095.

select

Riese DJ 2nd, Cullum RL. Epiregulin: roles in normal physiology and cancer. Semin Cell Dev Biol. 2014 Apr;28:49-56. doi: 10.1016/j.semcdb.2014.03.005. Epub 2014 Mar 12. Review. PubMed PMID: 24631357; PubMed Central PMCID: PMC4037385.

select

Gallo RM, Bryant IN, Mill CP, Kaverman S, Riese DJ 2nd. Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. J Cancer Res Ther Oncol. 2013 Aug 22;1(1):10. PubMed PMID: 24791013; PubMed Central PMCID: PMC4002051.

select

Allen RE, Copeland J, Franks AS, Karimi R, McCollum M, Riese DJ 2nd, Lin AY. Team-based learning in US colleges and schools of pharmacy. Am J Pharm Educ. 2013 Aug 12;77(6):115. doi: 10.5688/ajpe776115. PubMed PMID: 23966718; PubMed Central PMCID: PMC3748296.

select

Nickerson NK, Mill CP, Wu HJ, Riese DJ 2nd, Foley J. Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo. Oncol Res. 2013;20(7):303-17. doi: 10.3727/096504013x13639794277761. PubMed PMID: 23879171; PubMed Central PMCID: PMC3984049.

select

Foley J, Nickerson N, Riese DJ 2nd, Hollenhorst PC, Lorch G, Foley AM. At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone. Odontology. 2012 Jul;100(2):109-29. doi: 10.1007/s10266-012-0070-5. Epub 2012 Jun 10. Review. PubMed PMID: 22684584; PubMed Central PMCID: PMC3962551.

select

Wilson KJ, Mill C, Lambert S, Buchman J, Wilson TR, Hernandez-Gordillo V, Gallo RM, Ades LM, Settleman J, Riese DJ 2nd. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling. Growth Factors. 2012 Apr;30(2):107-16. doi: 10.3109/08977194.2011.649918. Epub 2012 Jan 20. Review. PubMed PMID: 22260327; PubMed Central PMCID: PMC3962550.

select

Wilson KJ, Mill CP, Gallo RM, Cameron EM, VanBrocklin H, Settleman J, Riese DJ. The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist. Biochem J. 2012 Apr 1;443(1):133-44. doi: 10.1042/BJ20110921. PubMed PMID: 22216880; PubMed Central PMCID: PMC3960720.

select

Mill CP, Zordan MD, Rothenberg SM, Settleman J, Leary JF, Riese DJ 2nd. ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer. Genes Cancer. 2011 Aug;2(8):792-804. doi: 10.1177/1947601911431080. PubMed PMID: 22393464; PubMed Central PMCID: PMC3278901.

select

Zordan MD, Mill CP, Riese DJ 2nd, Leary JF. A high throughput, interactive imaging, bright-field wound healing assay. Cytometry A. 2011 Mar;79(3):227-32. doi: 10.1002/cyto.a.21029. Epub 2011 Feb 9. PubMed PMID: 22045642; PubMed Central PMCID: PMC3306835.

select

Mill CP, Gettinger KL, Riese DJ 2nd. Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines. Exp Cell Res. 2011 Feb 15;317(4):392-404. doi: 10.1016/j.yexcr.2010.11.007. Epub 2010 Nov 24. PubMed PMID: 21110957; PubMed Central PMCID: PMC3022118.

select

Riese DJ 2nd. Ligand-based receptor tyrosine kinase partial agonists: New paradigm for cancer drug discovery?. Expert Opin Drug Discov. 2011 Feb;6(2):185-193. doi: 10.1517/17460441.2011.547468. PubMed PMID: 21532939; PubMed Central PMCID: PMC3083243.

select

Foley J, Nickerson NK, Nam S, Allen KT, Gilmore JL, Nephew KP, Riese DJ 2nd. EGFR signaling in breast cancer: bad to the bone. Semin Cell Dev Biol. 2010 Dec;21(9):951-60. doi: 10.1016/j.semcdb.2010.08.009. Epub 2010 Sep 9. Review. PubMed PMID: 20813200; PubMed Central PMCID: PMC2991402.

select

Coon BG, Mukherjee D, Hanna CB, Riese DJ 2nd, Lowe M, Aguilar RC. Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase. Hum Mol Genet. 2009 Dec 1;18(23):4478-91. doi: 10.1093/hmg/ddp407. Epub 2009 Aug 21. PubMed PMID: 19700499; PubMed Central PMCID: PMC7289333.

select

Gilmore JL, Gonterman RM, Menon K, Lorch G, Riese DJ 2nd, Robling A, Foley J. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone. Mol Cancer Res. 2009 Oct;7(10):1714-28. doi: 10.1158/1541-7786.MCR-09-0131. Epub 2009 Oct 13. PubMed PMID: 19825997; PubMed Central PMCID: PMC2784013.

select

Mill CP, Chester JA, Riese DJ 2nd. EGFR may couple moderate alcohol consumption to increased breast cancer risk. Breast Cancer (Dove Med Press). 2009 Oct 5;1:31-8. doi: 10.2147/bctt.s6254. Review. PubMed PMID: 24367161; PubMed Central PMCID: PMC2872252.

select

Wilson KJ, Gilmore JL, Foley J, Lemmon MA, Riese DJ 2nd. Functional selectivity of EGF family peptide growth factors: implications for cancer. Pharmacol Ther. 2009 Apr;122(1):1-8. doi: 10.1016/j.pharmthera.2008.11.008. Epub 2008 Dec 16. Review. PubMed PMID: 19135477; PubMed Central PMCID: PMC2665203.

select

Frogne T, Benjaminsen RV, Sonne-Hansen K, Sorensen BS, Nexo E, Laenkholm AV, Rasmussen LM, Riese DJ 2nd, de Cremoux P, Stenvang J, Lykkesfeldt AE. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant. Breast Cancer Res Treat. 2009 Mar;114(2):263-75. doi: 10.1007/s10549-008-0011-8. Epub 2008 Apr 14. PubMed PMID: 18409071; PubMed Central PMCID: PMC2764248.

select

Willmarth NE, Baillo A, Dziubinski ML, Wilson K, Riese DJ 2nd, Ethier SP. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell Signal. 2009 Feb;21(2):212-9. doi: 10.1016/j.cellsig.2008.10.003. Epub 2008 Oct 14. PubMed PMID: 18951974; PubMed Central PMCID: PMC2632975.

select

Przybyla JA, Cueva JP, Chemel BR, Hsu KJ, Riese DJ 2nd, McCorvy JD, Chester JA, Nichols DE, Watts VJ. Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors. Eur Neuropsychopharmacol. 2009 Feb;19(2):138-46. doi: 10.1016/j.euroneuro.2008.10.002. Epub 2008 Nov 22. PubMed PMID: 19028082; PubMed Central PMCID: PMC2636714.

select

Rothenberg SM, Engelman JA, Le S, Riese DJ 2nd, Haber DA, Settleman J. Modeling oncogene addiction using RNA interference. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12480-4. doi: 10.1073/pnas.0803217105. Epub 2008 Aug 18. PubMed PMID: 18711136; PubMed Central PMCID: PMC2517605.

select

Gilmore JL, Scott JA, Bouizar Z, Robling A, Pitfield SE, Riese DJ 2nd, Foley J. Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells. Breast Cancer Res Treat. 2008 Aug;110(3):493-505. doi: 10.1007/s10549-007-9748-8. Epub 2007 Sep 20. PubMed PMID: 17882547; PubMed Central PMCID: PMC2730887.

select

Wilson KJ, Mill CP, Cameron EM, Hobbs SS, Hammer RP, Riese DJ 2nd. Inter-conversion of neuregulin2 full and partial agonists for ErbB4. Biochem Biophys Res Commun. 2007 Dec 14;364(2):351-7. doi: 10.1016/j.bbrc.2007.10.004. Epub 2007 Oct 11. PubMed PMID: 17945187; PubMed Central PMCID: PMC2094732.

select

Gallo RM, Riese DJ 2nd. The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056. Growth Factors. 2007 Oct;25(5):329-33. doi: 10.1080/08977190701804008. PubMed PMID: 18236211; PubMed Central PMCID: PMC2435050.

select

Godin-Heymann N, Bryant I, Rivera MN, Ulkus L, Bell DW, Riese DJ 2nd, Settleman J, Haber DA. Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation. Cancer Res. 2007 Aug 1;67(15):7319-26. doi: 10.1158/0008-5472.CAN-06-4625. PubMed PMID: 17671201; PubMed Central PMCID: PMC2882853.

select

Riese DJ 2nd, Gallo RM, Settleman J. Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. Bioessays. 2007 Jun;29(6):558-65. doi: 10.1002/bies.20582. Review. PubMed PMID: 17508401; PubMed Central PMCID: PMC2789424.

select

Gallo RM, Bryant I, Fry R, Williams EE, Riese DJ 2nd. Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines. Biochem Biophys Res Commun. 2006 Oct 13;349(1):372-82. doi: 10.1016/j.bbrc.2006.08.055. Epub 2006 Aug 18. PubMed PMID: 16934755; PubMed Central PMCID: PMC1618953.

select

Gilmore JL, Gallo RM, Riese DJ 2nd. The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events. Biochem J. 2006 May 15;396(1):79-88. doi: 10.1042/BJ20051687. PubMed PMID: 16445385; PubMed Central PMCID: PMC1450006.

select

Pitfield SE, Bryant I, Penington DJ, Park G, Riese DJ 2nd. Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell lines. Oncol Res. 2006;16(4):179-93. doi: 10.3727/000000006783981134. PubMed PMID: 17120616; PubMed Central PMCID: PMC2788506.

select

Hobbs SS, Gallo RM, Riese DJ Jr. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*. Growth Factors. 2005 Dec;23(4):273-83. doi: 10.1080/08977190500199345. PubMed PMID: 16338790.

select

VanBrocklin HF, Lim JK, Coffing SL, Hom DL, Negash K, Ono MY, Gilmore JL, Bryant I, Riese DJ 2nd. Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes. J Med Chem. 2005 Nov 17;48(23):7445-56. doi: 10.1021/jm050607w. PubMed PMID: 16279804.

select

Hobbs SS, Cameron EM, Hammer RP, Le AT, Gallo RM, Blommel EN, Coffing SL, Chang H, Riese DJ 2nd. Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinase. Oncogene. 2004 Jan 29;23(4):883-93. doi: 10.1038/sj.onc.1207250. PubMed PMID: 14661053.

select

Gilmore JL, Riese DJ 2nd. secErbB4-26/549 antagonizes ligand-induced ErbB4 tyrosine phosphorylation. Oncol Res. 2004;14(11-12):589-602. doi: 10.3727/0965040042707907. PubMed PMID: 15667000.

select

Williams EE, Trout LJ, Gallo RM, Pitfield SE, Bryant I, Penington DJ, Riese DJ 2nd. A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell lines. Cancer Lett. 2003 Mar 20;192(1):67-74. doi: 10.1016/s0304-3835(02)00690-0. PubMed PMID: 12637154.

select

Hobbs SS, Coffing SL, Le AT, Cameron EM, Williams EE, Andrew M, Blommel EN, Hammer RP, Chang H, Riese DJ 2nd. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene. 2002 Dec 5;21(55):8442-52. doi: 10.1038/sj.onc.1205960. PubMed PMID: 12466964.

select

Walker-Daniels J, Riese DJ 2nd, Kinch MS. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res. 2002 Nov;1(1):79-87. PubMed PMID: 12496371.

select

Feroz K, Williams E, Riese DJ 2nd. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation. Cell Signal. 2002 Sep;14(9):793-8. doi: 10.1016/s0898-6568(02)00019-0. PubMed PMID: 12034361.